ArticlePlant biotechnology journal2026
CitPH4 Confers Resistance to Citrus Canker by Activating Papain-Like Cysteine Protease.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Citrus canker, a devastating disease caused by Xanthomonas citri subsp. citri (Xcc), poses a significant threat to global citrus production due to the high susceptibility of nearly all commercial citrus cultivars to it. Although transcription factor Citrus PH4 (CitPH4) is well known for regulating fruit acidity, its potential role in plant immunity remains elusive. Here, we demonstrate that CitPH4 positively regulates citrus defence against Xcc. Transcriptomic and biochemical analyses indicate that CitPH4 binds to the promoter of the responsive to dehydration 21a (CsRD21a), a gene encoding a papain-like cysteine protease (PLCP), thus modulating its expression. Functional characterisation further reveals that CsRD21a is essential for CitPH4-mediated resistance to Xcc. Mechanistically, CsRD21a interacts with pathogenesis-related protein 5 (CsPR5) to promote salicylic acid (SA) accumulation. In addition, reciprocal activation of PLCP activity and SA signalling enhances immune defences against Xcc. Collectively, our findings reveal a CitPH4-mediated citrus immunity mechanism in which the CitPH4-CsRD21a-CsPR5 module constitutes a defence loop by integrating reciprocal activation effects of PLCP activity and SA signalling. This study provides a novel insight into the regulatory network of citrus resistance against Xcc, offering potential targets for breeding citrus cultivars with enhanced disease resistance and superior fruit quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.